Journal of the Korean Pediatric Society 1980;23(10):791-797.
Published online October 15, 1980.
Therapeutic Effect of Rifampin in Shigellosis.
Chul Lee, Jun Hee Sul, Pyung Kil Kim, Duk Jin Yun
Department of Pediatirics, Yonsei University College of Medicine, Seoul, Korea.
세균성 이질에 서 Rifampin 의 치료효과
이 철, 설준희, 김병길, 윤덕진
연세대학교 의과대학 소아과학교실
Abstract
Twenty one infants and children were entered into the study protocol when bacteriologic diagnosis of shigellosis was made by stool culture indenification. Fifteen patients were treated at Inje Hospital in Kangwon Do and six patients were treated at Severance Hospital in Seoul. Susceptibility studies were revealed that ampicillin was resistant in all cases. Gentamicin and Panimycin which are aminoglycosides were quite effective. But their use was limited because of their nephrotoxicity and those antibiotics should be used only by parenteral route. A daily dose of 20microgram per kilogram of body weight of rifampin was given by mouth divided every 6 hrs for 7 days routinely except 2 cases. After that follow up stool culture were performed on 13 patient. The results were negative except one case. There was no untoward reaction of rifampin during therapy except for the red coloring of urine and stool. To prevent developing the resistance of shigella to rifampin, it is necessary to confirm that negative conversion of stool cultures has been achieved. Our experience should encourge the use of rifampin in the treatment of shigellosis.




Close layer
prev next